Latest News about JNJ
Recent news which mentions JNJ
From Motley Fool
5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market
November 29, 2021
From InvestorPlace
The world must plan now if we hope to prevent another pandemic as deadly and destructive as COVID-19
November 29, 2021
From MarketWatch
Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant
November 29, 2021
From Benzinga
Confused about whether to get a COVID booster? Here’s what to know
November 29, 2021
From MarketWatch
Who Would Be the Best FDA Commissioner for Biotech Investors?
November 28, 2021
From Motley Fool
Benzinga's Bulls And Bears Of The Past Week: Johnson & Johnson, Nike, Apple, Tesla And More
November 27, 2021
From Benzinga
Is Intuitive Surgical Stock a Buy?
November 27, 2021
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
Investors Turn to These 2 Nasdaq Stocks As the Market Falls
November 26, 2021
From Motley Fool
Better Buy: Johnson & Johnson or All 30 Dow Jones Stocks?
November 26, 2021
From Motley Fool
Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada
November 24, 2021
From Benzinga
U.S. has already seen more COVID deaths in 2021 than 2020 before vaccines were available, as experts again warn pandemic is not over
November 24, 2021
From MarketWatch
From Benzinga
Is It Too Late to Buy Intuitive Surgical Stock?
November 23, 2021
From Motley Fool
4 Reasons Pfizer Is Now the Ultimate COVID-19 Growth Stock
November 23, 2021
From Motley Fool
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
From Benzinga
Will Investors Benefit From Johnson & Johnson's Breakup?
November 23, 2021
From Motley Fool
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
From Motley Fool
EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks'
November 22, 2021
From Benzinga
7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation
November 22, 2021
From InvestorPlace
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
From Motley Fool
Ocugen Stock: Bull vs. Bear
November 20, 2021
From Motley Fool
GOOG vs. GOOGL: Everything You Need to Know About the Google Stock Split
November 19, 2021
From InvestorPlace
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio
November 19, 2021
From InvestorPlace
Inflation and Other News for Investors
November 17, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.